Rhodococcus equi is an intracellular veterinary pathogen that is becoming resistant to current antibiotherapy. Genes involved in preserving redox homeostasis could be promising targets for the development of novel anti-infectives. Here, we studied the role of an extracellular thioredoxin (Etrx3/REQ_13520) in the resistance to phagocytosis. An etrx3-null mutant strain was unable to survive within macrophages, whereas the complementation with the etrx3 gene restored its intracellular survival rate. In addition, the deletion of etrx3 conferred to R. equi a high susceptibility to sodium hypochlorite. Our results suggest that Etrx3 is essential for the resistance of R. equi to specific oxidative agents.
The extracellular thioredoxin Etrx3 is required for macrophage infection in Rhodococcus equi
Álvaro Mourenza,C. Collado,Natalia Bravo-Santano,J. Gil,L. M. Mateos,M. Letek
Published 2020 in Veterinary Research
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
Veterinary Research
- Publication date
2020-03-10
- Fields of study
Biology, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-30 of 30 references · Page 1 of 1
CITED BY
Showing 1-5 of 5 citing papers · Page 1 of 1